{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:00:37Z","timestamp":1783447237983,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803101"],"award-info":[{"award-number":["81803101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Tianjin Medical University","award":["2015KYZQ13"],"award-info":[{"award-number":["2015KYZQ13"]}]},{"name":"Postdoctoral Science Foundation of China","award":["2016M591398"],"award-info":[{"award-number":["2016M591398"]}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2016YD07"],"award-info":[{"award-number":["2016YD07"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172463","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:02:03Z","timestamp":1560625323000},"page":"172463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K\/Akt\/mTOR signaling pathway"],"prefix":"10.1016","volume":"858","author":[{"given":"Chun-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172463_bib1","first-page":"919","article-title":"EMT-associated factors promote invasive properties of uveal melanoma cells","volume":"21","author":"Asnaghi","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejphar.2019.172463_bib2","first-page":"72","article-title":"Periplocin promotes wound healing through the activation of Src\/ERK and PI3K\/Akt pathways mediated by Na\/K-ATPase","volume":"57","author":"Chen","year":"2018","journal-title":"Phytomed.Int. J. Phytother.Phytopharm."},{"key":"10.1016\/j.ejphar.2019.172463_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","article-title":"Co-targeting HGF\/cMET signaling with MEK inhibitors in metastatic uveal melanoma","volume":"16","author":"Cheng","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.172463_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1142\/S0192415X18500167","article-title":"Pharmacological effects of scutellarin, an active component of genus scutellaria and Erigeron: a systematic review","volume":"46","author":"Chledzik","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejphar.2019.172463_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ctrv.2018.11.001","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in biliary tract cancers: a review of current evidences and future perspectives","volume":"72","author":"Corti","year":"2019","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejphar.2019.172463_bib6","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.biopha.2018.08.127","article-title":"Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN","volume":"107","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother. Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2019.172463_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2019.172463_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040378","article-title":"The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion","volume":"7","author":"Fenouille","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172463_bib9","first-page":"273","article-title":"Glucose affects cell viability, migration, angiogenesis and cellular adhesion of human retinal capillary endothelial cells via SPARC","volume":"17","author":"Fu","year":"2019","journal-title":"Exp. Ther.Med."},{"key":"10.1016\/j.ejphar.2019.172463_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2018.07.028","article-title":"Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria","volume":"80","author":"Gastman","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2019.172463_bib11","first-page":"2098","article-title":"Endogenous Nodal promotes melanoma undergoing epithelial-mesenchymal transition via Snail and Slug in vitro and in vivo","volume":"5","author":"Guo","year":"2015","journal-title":"Am. J. Cancer.Res."},{"key":"10.1016\/j.ejphar.2019.172463_bib12","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/molecules19055748","article-title":"In vitro inhibitory effects of scutellarin on six human\/rat cytochrome P450 enzymes and P-glycoprotein","volume":"19","author":"Han","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2019.172463_bib13","first-page":"129","article-title":"An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma","volume":"32","author":"Hintsala","year":"2017","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ejphar.2019.172463_bib14","first-page":"1","article-title":"Study on attenuating angiogenesis and epithelial-mesenchymal transition (EMT) of non-small cell lung carcinoma (NSCLC) by regulating MAGEC2","volume":"17","author":"Jiang","year":"2018","journal-title":"Technol. Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.172463_bib15","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/cas.13791","article-title":"Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and gamma-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells","volume":"109","author":"Kim","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2019.172463_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3892\/mmr.2017.6905","article-title":"Traditional Chinese medicine, Fuzheng KangAi decoction, inhibits metastasis of lung cancer cells through the STAT3\/MMP9 pathway","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2019.172463_bib17","first-page":"6230","article-title":"Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2019.172463_bib18","first-page":"99","article-title":"The combination of NVP-BEZ235 and rapamycin regulates nasopharyngeal carcinoma cell viability and apoptosis via the PI3K\/AKT\/mTOR pathway","volume":"17","author":"Luo","year":"2019","journal-title":"Exp. Ther.Med."},{"key":"10.1016\/j.ejphar.2019.172463_bib19","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.bmcl.2018.08.034","article-title":"Eupatilin inhibits angiogenesis-mediated human hepatocellular metastasis by reducing MMP-2 and VEGF signaling","volume":"28","author":"Park","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2019.172463_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/molecules21091258","article-title":"Antiangiogenic effects of VH02, a novel urea derivative: in vitro and in vivo studies","volume":"21","author":"Phowichit","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2019.172463_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.21873\/anticanres.11354","article-title":"Selumetinib inhibits melanoma metastasis to mouse liver via suppression of EMT-targeted genes","volume":"37","author":"Ryu","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.172463_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgf2.200","article-title":"Diagnostic clue for pleural metastasis of malignant melanoma","volume":"19","author":"Saraya","year":"2018","journal-title":"J. Gen. Mol.Fam. Med."},{"key":"10.1016\/j.ejphar.2019.172463_bib23","first-page":"5191","article-title":"Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6mediated pathways in vivo and in vitro","volume":"18","author":"Shi","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2019.172463_bib24","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1208\/s12248-017-0134-0","article-title":"A flavonoid glycoside compound from murraya paniculata (L.) interrupts metastatic characteristics of A549 cells by regulating STAT3\/NF-kappaB\/COX-2 and EGFR signaling pathways","volume":"19","author":"Shi","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2019.172463_bib25","first-page":"8640","article-title":"MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression","volume":"22","author":"Sun","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2019.172463_bib26","first-page":"965","article-title":"Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9","volume":"17","author":"Sun","year":"2019","journal-title":"Oncology letters"},{"key":"10.1016\/j.ejphar.2019.172463_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000289569","article-title":"VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K\/AKT\/mTOR pathway","volume":"91","author":"Villaume","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejphar.2019.172463_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-017-3248-x","article-title":"Coordinated targeting of MMP-2\/MMP-9 by miR-296-3p\/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma","volume":"445","author":"Wang","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2019.172463_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lfs.2016.01.018","article-title":"Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress","volume":"157","author":"Wang","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.172463_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/mmr.2016.6081","article-title":"Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway","volume":"15","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2019.172463_bib32","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3892\/or.2016.4664","article-title":"Rhapontigenin inhibits TGF-beta-mediated epithelialmesenchymal transition via the PI3K\/AKT\/mTOR pathway and is not associated with HIF-1alpha degradation","volume":"35","author":"Yeh","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2019.172463_bib33","first-page":"3921","article-title":"UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K\/AKT\/mTOR pathway in triple negative breast cancer MDA-MB-231 cells","volume":"16","author":"Yue","year":"2018","journal-title":"Exp. Ther.Med."},{"key":"10.1016\/j.ejphar.2019.172463_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2014.11.012","article-title":"Piperine inhibits proliferation of human osteosarcoma cells via G2\/M phase arrest and metastasis by suppressing MMP-2\/-9 expression","volume":"24","author":"Zhang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2019.172463_bib35","first-page":"5094","article-title":"Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2","volume":"9","author":"Zhu","year":"2017","journal-title":"Am. J. Tourism Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T18:44:00Z","timestamp":1569091440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919304157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S0014299919304157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172463","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K\/Akt\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172463"}}